Clinical trial
Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
NCT01657942 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- May 31, 2021
- Enrollment
- 101 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
localized intermediate risk prostate lesions